ACUTE MYELOID LUKEMIA

Clinical trials for ACUTE MYELOID LUKEMIA explained in plain language.

Never miss a new study

Get alerted when new ACUTE MYELOID LUKEMIA trials appear

Sign up with your email to follow new studies for ACUTE MYELOID LUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo aims to outsmart aggressive leukemia

Disease control Completed

This trial tests whether adding the targeted drug ponatinib to standard chemotherapy (cytarabine) can help prevent relapse in adults with a specific, high-risk genetic form of acute myeloid leukemia (FLT3-ITD AML) who are already in first remission. The study includes two age gro…

Matched conditions: ACUTE MYELOID LUKEMIA

Phase: PHASE1, PHASE2 • Sponsor: Versailles Hospital • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC

ACUTE MYELOID LUKEMIA

Get alerted when new ACUTE MYELOID LUKEMIA trials appear

New drug combo aims to outsmart aggressive leukemia